Franquet, T, Gimenez, A, Ketai, L, Mazzini, S, Rial, A, Pomar, V, Domingo, P. Air trapping in COVID-19 patients following hospital discharge: retrospective evaluation with paired inspiratory/expiratory thin-section CT. EUROPEAN RADIOLOGY. 2022; 32(7)DOI:10.1007/s00330-022-08580-2. PMID:35226158. IF:5.900(Q1/2D).

Capdevila, J, Gomez, MA, Guillot, M, Paez, D, Pericay, C, Safont, MJ, Tarazona, N, Vera, R, Vidal, J, Sastre, J. SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer (2021) (vol 24, pg 646, 2022). Clinical & Translational Oncology. 2022; 24(7)DOI:10.1007/s12094-022-02855-2. PMID:35596046. IF:3.400(Q3/6D).

Majem, M, de las Penas, R, Virizuela, JA, Cabezon-Gutierrez, L, Cruz, P, Lopez-Castro, R, Mendez, M, Mondejar, R, Munoz, MD, Escobar, Y. SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2021) (vol 24, pg 712, 2022). Clinical & Translational Oncology. 2022; 24(7)DOI:10.1007/s12094-022-02846-3. PMID:35567734. IF:3.400(Q3/6D).

Maroto, P, Porta, C, Capdevila, J, Apolo, AB, Viteri, S, Rodriguez-Antona, C, Martin, L, Castellano, D. Cabozantinib for the treatment of solid tumors: a systematic review. Therapeutic Advances in Medical Oncology. 2022; 14DOI:10.1177/17588359221107112. PMID:35847482. IF:4.900(Q2/4D).

Castellano, D, Apolo, AB, Porta, C, Capdevila, J, Viteri, S, Rodriguez-Antona, C, Martin, L, Maroto, P. Cabozantinib combination therapy for the treatment of solid tumors: a systematic review. Therapeutic Advances in Medical Oncology. 2022; 14DOI:10.1177/17588359221108691. PMID:35923927. IF:4.900(Q2/4D).

Parra-Perez, AM, Perez-Jimenez, A, Gris-Cardenas, I, Bonel-Perez, GC, Carrasco-Diaz, LM, Mokhtari, K, Garcia-Salguero, L, Lupianez, JA, Rufino-Palomares, EE. Involvement of the PI3K/AKT Intracellular Signaling Pathway in the AntiCancer Activity of Hydroxytyrosol, a Polyphenol from Olea europaea, in Hematological Cells and Implication of HSP60 Levels in Its Anti-Inflammatory Activity. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(13)DOI:10.3390/ijms23137053. PMID:35806065. IF:5.600(Q1/3D).

Alvarez-Larran, A, Garrote, M, Ferrer-Marin, F, Perez-Encinas, M, Mata-Vazquez, MI, Bellosillo, B, Arellano-Rodrigo, E, Gomez, M, Garcia, R, Garcia-Gutierrez, V, Gasior, M, Cuevas, B, Angona, A, Gomez-Casares, MT, Martinez, CM, Magro, E, Ayala, R, del Orbe-Barreto, R, Perez-Lopez, R, Fox, ML, Raya, JM, Guerrero, L, Garcia-Hernandez, C, Caballero, G, Murillo, I, Xicoy, B, Ramirez, MJ, Carreno-Tarragona, G, Hernandez-Boluda, JC, Pereira, A. Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea. CANCER. 2022; 128(13)DOI:10.1002/cncr.34195. PMID:35417564. IF:6.200(Q1/3D).

Lop, J, Venegas, MD, Pujol, A, Sauter, B, Vasquez, R, Casasayas, M, Quer, M, Leon, X. Causes of long-term mortality in patients with head and neck squamous cell carcinomas. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY. 2022; 279(7)DOI:10.1007/s00405-021-07211-8. PMID:34905065. IF:2.600(Q2/3D).

Leon, X, Garcia, J, Pujol, A, de Juan, J, Vasquez, R, Quer, M, Camacho, M. Relationship between the transcriptional expression of PIM1 and local control in patients with head and neck squamous cell carcinomas treated with radiotherapy. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY. 2022; 279(7)DOI:10.1007/s00405-021-07223-4. PMID:34993612. IF:2.600(Q2/3D).

Alonso, LG, Aizpurua, DA, Alvarez, XM, Serra, LA, Sanabria, MT, Li, CH. Percutaneous closure of left ventricular pseudoaneurysm. Case resolution. REC, interventional cardiology. 2022; 4(3)DOI:10.24875/RECICE.M22000285. PMID:. IF:(Q/D).

Alonso, LG, Aizpurua, DA, Alvarez, XM, Serra, LA, Sanabria, MT, Li, CH. Percutaneous closure of left ventricular pseudoaneurysm. REC, interventional cardiology. 2022; 4(3)DOI:10.24875/RECICE.M22000284. PMID:. IF:(Q/D).

Mazuecos, A, Villanego, F, Zarraga, S, Lopez, V, Oppenheimer, F, Llinas-Mallol, L, Hernandez, AM, Rivas, A, Ruiz-Fuentes, MC, Toapanta, NG, Jimenez, C, Cabello, S, Beneyto, I, Aladren, MJ, Rodriguez-Benot, A, Canal, C, Molina, M, Perez-Flores, I, Saura, IM, Gavela, E, Franco, A, Lorenzo, I, Galeano, C, Tabernero, G, Perez-Tamajon, L, Martin-Moreno, PL, Fernandez-Giron, F, Siverio, O, Labrador, PJ, De Arriba, G, Simal, F, Cruzado, L, Moina, I, Alcalde, G, Sanchez-Alvarez, E, Pascual, J, Crespo, M. Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination in Kidney Transplant Recipients. TRANSPLANTATION. 2022; 106(7)DOI:10.1097/TP.0000000000004119. PMID:35384924. IF:6.200(Q1/1D).

Quilis, N, Vela, P, Caceres, BAB, Diaz-Torne, C, Calvo-Aranda, E, Sivera, F, Prada-Ojeda, A, Ruiz, FP, Pascual, E, Andres, M. Cutaneous adverse events with febuxostat after previous reactions to allopurinol: comment on the article by Singh and Cleveland. ANNALS OF THE RHEUMATIC DISEASES. 2022; 81(7)DOI:10.1136/annrheumdis-2020-218226. PMID:32616605. IF:27.400(Q1/1D).

Puertolas-Gracia, B, Barbaglia, MG, Gotsens, M, Pares-Badell, O, Brugal, MT, Torrens, M, Trevino, L, Rodriguez-Diaz, C, Vazquez-Vazquez, JM, Pascual, A, Coromina-Gimferrer, M, Jimenez-Duenas, M, Oliva, I, Gonzalez, E, Mestre, N, Bartroli, M. Lifetime Dual Disorder Screening and Treatment Retention: A Pilot Cohort Study. Journal of Clinical Medicine. 2022; 11(13)DOI:10.3390/jcm11133760. PMID:35807045. IF:3.900(Q2/4D).

Casabella-Ramon, S, Jimenez-Sabado, V, Tarifa, C, Casellas, S, Lu, TT, Izquierdo-Castro, P, Gich, I, Jimenez, M, Ginel, A, Guerra, JM, Chen, SRW, Benitez, R, Hove-Madsen, L. Impact of R-Carvedilol on beta 2-Adrenergic Receptor-Mediated Spontaneous Calcium Release in Human Atrial Myocytes. Biomedicines. 2022; 10(7)DOI:10.3390/biomedicines10071759. PMID:35885069. IF:4.700(Q1/3D).

Sanguedolce, F, Meneghetti, I, Bevilacqua, G, Montano, B, Martinez, C, Territo, A, Balana, J, Palou, J, Breda, A. Intravesical instillation with glycosaminoglycan replacement treatment in patients suffering radiation-induced haemorrhagic cystitis: When and which patients can benefit most from it?. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 2022; 40(7)DOI:10.1016/j.urolonc.2022.02.013. PMID:35400568. IF:2.700(Q2/5D).

Ars, E, Bernis, C, Fraga, G, Furlano, M, Martinez, V, Martins, J, Ortiz, A, Perez-Gomez, MV, Rodriguez-Perez, JC, Sans, L, Torra, R. Consensus document on autosomal dominant polycystic kindey disease from the Spanish Working Group on Inherited Kindey Diseases. Review 2020. NEFROLOGIA. 2022; 42(4)DOI:10.1016/j.nefro.2021.05.009. PMID:36404270. IF:2.600(Q3/6D).

Canada-Garcia, JE, Moure, Z, Sola-Campoy, PJ, Delgado-Valverde, M, Cano, ME, Gijon, D, Gonzalez, M, Gracia-Ahufinger, I, Larrosa, N, Mulet, X, Pitart, C, Rivera, A, Bou, G, Calvo, J, Canton, R, Gonzalez-Lopez, JJ, Martinez-Martinez, L, Navarro, F, Oliver, A, Palacios-Baena, ZR, Pascual, A, Ruiz-Carrascoso, G, Vila, J, Aracil, B, Perez-Vazquez, M, Oteo-Iglesias, J. CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3. Frontiers in Microbiology. 2022; 13DOI:10.3389/fmicb.2022.918362. PMID:35847090. IF:5.200(Q2/3D).

Saumoy, M, Sanchez-Quesada, JL, Assoumou, L, Gatell, JM, Gonzalez-Cordon, A, Guaraldi, G, Domingo, P, Giacomelli, A, Connault, J, Katlama, C, Masia, M, Ordonez-Llanos, J, Pozniak, A, Martinez, E, Podzamczer, D. Atherogenicity of low-density lipoproteins after switching from a protease inhibitor to dolutegravir: a substudy of the NEAT022 study. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2022; 77(7)DOI:10.1093/jac/dkac117. PMID:35411401. IF:5.200(Q1/3D).

Pollard, JA, Furutani, E, Liu, SS, Esrick, E, Cohen, LE, Bledsoe, J, Liu, CW, Lu, K, de Haro, MJR, Sumalles, J, Malsch, M, Kuniholm, A, Galvin, A, Armant, M, Kim, AS, Ballotti, K, Moreau, L, Zhou, Y, Babushok, D, Boulad, F, Carroll, C, Hartung, H, Hont, A, Nakano, T, Olson, T, Sze, SG, Thompson, AA, Wlodarski, MW, Gu, XS, Libermann, TA, D'Andrea, A, Grompe, M, Weller, E, Shimamura, A. Metformin for treatment of cytopenias in children and young adults with Fanconi anemia. Blood Advances. 2022; 6(12)DOI:10.1182/bloodadvances.2021006490. PMID:35500223. IF:7.500(Q1/2D).